Literature DB >> 8207722

Hyperventilation in patients who have sustained myocardial infarction after a work injury.

S D Rosen1, J C King, P G Nixon.   

Abstract

Patients who present with acute myocardial infarction after a work injury (AMI-WI) often report symptoms consistent with chronic hyperventilation which date back as far as the work injury itself, rather than to the AMI. The aim of the study was to test the hypothesis that hyperventilation significantly contributes to the symptoms of AMI-WI patients. The prevalence of hyperventilation was assessed by clinical capnography in 12 AMI-WI patients, 20 normal controls, 15 AMI patients whose AMI was conventional and not subsequent to a work injury (AMI-C) and 14 patients with post-traumatic stress disorder (PTSD). End-tidal carbon dioxide partial pressure (P(et)CO2) was measured at rest, after 1 min hyperventilation (FHPT), after recall of the relevant stressor (Think) and when the breathing was felt to be normal (MBIN). P(et)CO2 levels after FHPT were: 29.0 +/- 1.5 (mean +/- SD) mmHg for AMI-WI; 26.7 +/- 1.9 mmHg for PTSD; 32.1 +/- 4.1 mmHg for AMI-C and 33.7 +/- 1.4 mmHg for the controls (P < 0.05 and P < 0.01 for AMI-WI and PTSD, respectively, versus controls). After Think, the levels were 25.8 +/- 1.6 mmHg for AMI-WI, 24.6 +/- 1.4 mmHg for PTSD, 31.2 +/- 4.1 mmHg for AMI-C and 31.2 +/- 1.5 mmHg for normals (P < 0.05 and P < 0.01 for AMI-WI and PTSD, respectively, versus controls). For MBIN, values of P(et)CO2 were 26.8 +/- 1.7 mmHg and 26.7 +/- 1.5 mmHg for AMI-WI and PTSD versus 33.8 +/- 1.2 mmHg for normals, (P < 0.01 for both versus controls).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8207722      PMCID: PMC1294518          DOI: 10.1177/014107689408700511

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

1.  Sensory and information inputs overload: behavioral effects.

Authors:  Z J Lipowski
Journal:  Compr Psychiatry       Date:  1975 May-Jun       Impact factor: 3.735

2.  Delayed habituation of the electrodermal orienting response as a function of increased level of arousal.

Authors:  G Bohlin
Journal:  Psychophysiology       Date:  1976-07       Impact factor: 4.016

3.  The influence of precombat personality on posttraumatic stress disorder.

Authors:  H Hendin; A P Haas; P Singer; F Gold; G G Trigos
Journal:  Compr Psychiatry       Date:  1983 Nov-Dec       Impact factor: 3.735

4.  Hyperventilation and panic attacks.

Authors:  M J Hoes; P Colla; P van Doorn; H Folgering; J de Swart
Journal:  J Clin Psychiatry       Date:  1987-11       Impact factor: 4.384

5.  The 'think test': a further technique to elicit hyperventilation.

Authors:  P G Nixon; L J Freeman
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

6.  Alkalosis-induced coronary vasoconstriction: effects of calcium, diltiazem, nitroglycerin, and propranolol.

Authors:  H Yasue; S Omote; A Takizawa; M Nagao; K Nosaka; H Nakajima
Journal:  Am Heart J       Date:  1981-08       Impact factor: 4.749

7.  Inappropriate ventilation and hypoxemia as causes of cardiac arrhythmias. The control of arrhythmias without antiarrhythmic drugs.

Authors:  S M Ayres; W J Grace
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

Review 8.  Role of magnesium in cardiac disease.

Authors:  H Ebel; T Günther
Journal:  J Clin Chem Clin Biochem       Date:  1983-05

9.  Failure of perception of hypocapnia: physiological and clinical implications.

Authors:  J C King; S D Rosen; P G Nixon
Journal:  J R Soc Med       Date:  1990-12       Impact factor: 18.000

Review 10.  Hyperventilation syndromes in medicine and psychiatry: a review.

Authors:  L C Lum
Journal:  J R Soc Med       Date:  1987-04       Impact factor: 18.000

View more
  1 in total

1.  Hyperventilation in patients who have sustained myocardial infarction after a work injury.

Authors:  S D Rosen; J C King; P G Nixon
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.